Startups
University Health Network (UHN) is Canada's largest research hospital, which includes Toronto General and Toronto Western Hospitals, Princess Margaret Cancer Centre, the Toronto Rehabilitation Institute and the Michener Institute for Education at UHN. The scope of research and complexity of cases at UHN has made it a national and international source for research, education and patient care.
UHN is a research hospital affiliated with the University of Toronto, with major research in cardiology, transplantation, neurosciences, oncology, surgical innovation, infectious diseases, genomic medicine and rehabilitation medicine.
The Toronto General & Western Hospital Foundation, The Princess Margaret Cancer Foundation and Toronto Rehab Foundation allow us to fulfill our purpose by engaging our generous donor community and raising critical funds for research, education and improving the experience of our patients.
Our Purpose:
Transforming lives and communities through excellence in care, discovery and learning.
Our Primary Value:
The needs of patients come first.
Our Values:
Safety, compassion, teamwork, integrity and stewardship.
UHN is a research hospital affiliated with the University of Toronto, with major research in cardiology, transplantation, neurosciences, oncology, surgical innovation, infectious diseases, genomic medicine and rehabilitation medicine.
The Toronto General & Western Hospital Foundation, The Princess Margaret Cancer Foundation and Toronto Rehab Foundation allow us to fulfill our purpose by engaging our generous donor community and raising critical funds for research, education and improving the experience of our patients.
Our Purpose:
Transforming lives and communities through excellence in care, discovery and learning.
Our Primary Value:
The needs of patients come first.
Our Values:
Safety, compassion, teamwork, integrity and stewardship.
Overview
Location
Canada, Ontario, Toronto
Employees
10001+
Total raised
$3M
Founded date
1999
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 34
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Oct 7, 2026 | Ambea and AGE-WELL partner to advance innovation and technology in senior care | Ambea and AGE-WELL partner to advance innovation and technology in senior care Wed, Oct 07, 2026 15:09 CET Report this content Ambea, a leading Nordic care provider, and AGE-WELL, Canada’s technology and aging network, have formed a strateg... |
| Mar 24, 2026 | Enamine Joins Agora Open Science Trust and Variational AI to Advance Open-Science Discovery of PRMT6 Inhibitors | KYIV, UKRAINE, March 24, 2026 /EINPresswire.com/ -- Enamine, a leading integrated drug discovery contract research organization (CRO) has today announced its participation in an open-science collaboration with Variational AI and the Agora O... |
| Feb 25, 2026 | Canadian hospital now ranked #2 in the world | UHN achieves highest-ever position in Newsweek's World's Best Hospitals ranking TORONTO, Feb. 25, 2026 /PRNewswire/ -- University Health Network's Toronto General Hospital has ranked second in the world in Newsweek magazine's World's Best H... |
| Oct 2, 2025 | Huron Technologies Announces Strategic Collaboration with University Health Network | TORONTO, ONTARIO, CANADA, October 2, 2025 /EINPresswire.com/ -- Division of Huron Technologies International Inc. 1620 King Street North, PO Box 504 St. Jacobs, ON, Canada, N0B 2N0 TEL: (519) 886-9013 FAX: (519) 886-5300 www.hurontechnologi... |
| Aug 26, 2025 | Neogap appoints leading international cell therapy expert to its Board | Neogap appoints leading international cell therapy expert to its Board Tue, Aug 26, 2025 06:30 CET Report this content Neogap Therapeutics AB, a Swedish clinical-stage biotechnology company developing personalised immunotherapy for cancer t... |
| Jun 4, 2025 | ProteinQure's $11 Million Leap: A New Era for Peptide Therapeutics | In the world of biotechnology, innovation is the lifeblood. ProteinQure, a Toronto-based company, has just taken a significant step forward by securing $11 million in Series A funding. This financial boost, led by Tom Williams of Heron Rock... |
| Jun 3, 2025 | ProteinQure: $11 Million Series A Raised For Computational Peptide Therapeutics | ProteinQure, a computational peptide therapeutics company, announced the closing of an $11 million Series A financing round. The funding round was led by Tom Williams of Heron Rock Fund, with participation from Golden Ventures, Kensington C... |
| Apr 8, 2025 | Canada’s Bold Leap: Attracting Global Talent to Fuel Health Innovation | In a world where health challenges loom large, Canada is stepping up. The University Health Network (UHN) in Toronto has launched the Canada Leads 100 Challenge. This initiative aims to recruit 100 of the brightest early-career scientists f... |
| Apr 8, 2025 | Canada Leads: Canada's No. 1 Hospital Announces Strategy to Attract World's Most Promising Scientists, Drive Health Innovation and Economic Growth | TORONTO, April 8, 2025 /PRNewswire/ -- In a bold move to position Canada as the ultimate destination for the brightest minds in medical research, whose work will help build our future economy, University Health Network (UHN) is unveiling th... |
Show more
Reviews 0
FAQ about University Health Network
When was University Health Network founded?
University Health Network was founded in 1999.
How much funding has University Health Network raised?
University Health Network has raised $3M in total across 1 funding round.
What has the press written about University Health Network?
Parsers VC has collected 34 articles mentioning University Health Network, among them “Ambea and AGE-WELL partner to advance innovation and technology in senior care” (Oct 7, 2026) and “Enamine Joins Agora Open Science Trust and Variational AI to Advance Open-Science Discovery of PRMT6 Inhibitors” (Mar 24, 2026).
Is University Health Network still active?
Yes, University Health Network is active; its latest activity on Parsers VC dates from Oct 15, 2026.